Hale Capital Partners, LP - Mar 12, 2025 Form 4 Insider Report for Vislink Technologies, Inc. (VISL)

Role: 10%+ Owner
Signature: Martin M. Hale, Jr., Managing Member of Hale Fund Partners, LLC, general partner of Hale Capital Partners, LP
Stock symbol: VISL
Transactions as of: Mar 12, 2025
Transactions value $: $473,505
Form type: 4
Date filed: 3/14/2025, 06:39 PM
Previous filing: Mar 11, 2025
Next filing: Mar 27, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VISL	Common Stock par value $0.00001 per share	Purchase	$472K	+185	+0.05%	$2,554.00^*	366K	Mar 12, 2025	See footnote	F1
transaction	VISL	Common Stock par value $0.00001 per share	Purchase	$1.02K	+400	+0.11%	$2.54	366K	Mar 13, 2025	See footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares of Common Stock par value $0.00001 per share (the "Shares") of Vislink Technologies, Inc. are directly beneficially owned by Hale Capital Partners, LP ("HCP"). As the CEO of HCP and managing member of Hale Fund Partners, LLC ("HFP"), Martin M. Hale, Jr. may be deemed to beneficially own the shares. As the general partner of Hale Capital Management, LP ("HCM"), the investment manager of HCP, Hale Fund Management, LLC ("HFM") may be deemed to beneficially own the Shares. As the general partner of HCP, Hale Fund Partners, LLC may be deemed to beneficially own the Shares.

Content

The shares of Common Stock par value $0.00001 per share (the "Shares") of Vislink Technologies, Inc. are directly beneficially owned by Hale Capital Partners, LP ("HCP"). As the CEO of HCP and managing member of Hale Fund Partners, LLC ("HFP"), Martin M. Hale, Jr. may be deemed to beneficially own the shares. As the general partner of Hale Capital Management, LP ("HCM"), the investment manager of HCP, Hale Fund Management, LLC ("HFM") may be deemed to beneficially own the Shares. As the general partner of HCP, Hale Fund Partners, LLC may be deemed to beneficially own the Shares.